Artificial Intelligence | Machine Learning METiS Therapeutics | Develop and Deliver Revolutionary Therapies


Enterprise, Biotechnology, Pharmaceutical, Drug Discovery, Drug Development, API Solutions, Therapeutic Cambridge , MA , United States

METiS Therapeutics

Artificial Intelligence | Machine Learning


METiS Therapeutics | Develop and Deliver Revolutionary Therapies

METiS Therapeutics

Biotechnology, Pharmaceutical, Drug Discovery, Drug Development, API Solutions, Therapeutic


Cambridge , MA , United States

The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design. Founded by a team of MIT researchers, serial entrepreneurs and biotech industry veterans, METiS develops and in-licenses novel assets with high therapeutic potential that could benefit from its data-driven platform.

 

B2B

1 to 25

N/A

N/A

Scaling Up

N/A

 
 

Pharmaceuticals
Biotechnology

N/A

N/A

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning


Drug Discovery

Drug Discovery


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

Director/ Senior Director

Cambridge, MA

Sr. Manager / Associate Director

Cambridge, MA

 

AI/ML Professionals

Want to work at METiS Therapeutics?

We can introduce you to the right person at METiS Therapeutics

Talk to our Talent Team

 

6

1

$86M

Company was founded -0001 and it took almost 2022 years (Dec 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

12/07/2021

Series A

$86M

5Y Capital, PICC Group, China Life, Sequoia Capital India, Lightspeed Venture Partners, FreeS Fund

Date : 12/07/2021

Round: Series A

$ Raised: $86M

Investors: 5Y Capital, PICC Group, China Life, Sequoia Capital India, Lightspeed Venture Partners, FreeS Fund

 

Investors

Interested in researching METiS Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about METiS Therapeutics

Request a Demo - Deal Souring Platform

 
Takayo Inoue


Takayo Inoue
Senior Director and Head of Clinical Pharmacology

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ METiS Therapeutics